![]() |
市場調查報告書
商品編碼
1764952
北美外周栓塞線圈市場預測(至2031年)-區域分析(按類型、材料和應用)North America Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application |
2023 年北美周邊栓塞線圈市場價值為 2.4786 億美元,預計到 2031 年將達到 3.6053 億美元;預計 2023 年至 2031 年的複合年成長率為 4.8%。
主動脈瘤丟失盛行率上升推動北美周邊栓塞線圈市場
主動脈瘤是人體主要動脈或主動脈的膨出壁。根據美國心臟協會 2023 年的資料,2020 年全球報告的死亡人數為 15 萬人,比 2010 年增加了 26%。吸菸者和女性的動脈瘤破裂率較高。目前,尚無有效藥物可預防主動脈瘤的發展;唯一的治療方法是手術或血管內修復。栓塞劑通常用作開放性手術的替代品,而開放性手術風險更高,恢復期也更長。周邊血管栓塞線圈、氰基丙烯酸酯或纖維蛋白膠、凝膠泡沫和 Onyx 是常用於治療主動脈瘤內漏的栓塞裝置。栓塞術是治療周邊動脈瘤的理想選擇,因為它比開放性手術修復的創傷更小。此外,栓塞術也可用於選擇性治療某些先天性心臟病、瘻管、動脈瘤以及冠狀動脈繞道術後的動脈側支盜血症候群。因此,主動脈瘤盛行率的上升推動了周邊栓塞栓塞術市場的成長。
北美周邊栓塞線圈市場概況
基於美國、加拿大和墨西哥的市場狀況,本文對北美周邊栓塞線圈市場進行了分析。大腸直腸癌和創傷盛行率的激增是推動該地區市場成長的主要因素。大腸直腸癌是墨西哥第四大常見癌症,大多數病例發生在50歲以後,男女病例分佈相似。因此,隨著預期壽命的延長,新病例數和死亡率也穩定上升。由於周邊動脈疾病(PAD)和動脈瘤等血管疾病的盛行率不斷上升,需要微創治療方案,美國周邊栓塞線圈市場正在經歷成長。周邊栓塞線圈對於血管內栓塞至關重要,可以防止出血或減少目標區域的血流量。隨著醫療保健提供者專注於透過微創手術改善患者預後,對這些線圈的需求正在上升。技術進步,例如更有效率和生物相容性的線圈的開發,以及人們對血管內治療的認知不斷提高,正在進一步推動美國市場的擴張。
墨西哥的癌症發生率正在上升,大腸直腸癌位列第三大常見癌症。根據IMSS的數據,該國每年約有1.5萬例結腸癌新病例。預計墨西哥的結直腸癌市場將持續成長,以推動癌症早期發現運動。根據GLOBOCAN的數據,2020年墨西哥的胃癌發生率為6.2%,死亡率為每十萬人4.7人。微線圈栓塞術是一種成熟的上消化道出血治療方法,可在更靠近出血部位的位置進行。使用超選擇性導管進行的手術是治療急性下消化道出血的安全有效的方法。根據Statista的數據,2021年加拿大每10萬例住院病例中約有600例是因創傷住院。根據《加拿大外科雜誌》(CJS)2021年發表的一篇文章,經動脈栓塞術已成功用於治療非脾臟創傷;最常見的栓塞技術是使用凝膠泡沫栓塞。這些手術成功率高,併發症發生率低。此外,加拿大衛生部已批准多種用於治療顱內動脈瘤的彈簧圈和彈簧圈輸送系統。彈簧圈栓塞術可與其他輔助血管內裝置(如支架和球囊)搭配使用。
北美周邊栓塞線圈市場收入及預測(2031 年)(百萬美元)
北美周邊栓塞線圈市場細分
北美外周栓塞線圈市場按類型、材料、應用和國家分類。
根據類型,北美外周栓塞線圈市場分為可分離線圈和可推動線圈。 2023年,可分離線圈佔據了較大的市佔率。
就材質而言,北美周邊栓塞線圈市場分為鉑金、鉑金水凝膠以及鉑鎢合金。鉑金在2023年佔據了最大的市場佔有率。
根據應用,北美周邊栓塞線圈市場細分為出血和創傷、畸形、腫瘤、內臟動脈瘤、II型內漏和靜脈曲張。出血和創傷領域在2023年佔據了最大的市場。
根據國家/地區,北美周邊栓塞線圈市場分為美國、加拿大和墨西哥。 2023年,美國佔據了北美周邊栓塞線圈市場的主導地位。
Medtronic Plc、Penumbra, Inc.、Balt、Boston Scientific Corp、Cook Medical Holdings LLC、Wallaby Medical、Spartan Micro Inc. 和 Terumo Corp. 是北美外周栓塞線圈市場的一些領先公司。
The North America peripheral embolization coils market was valued at US$ 247.86 million in 2023 and is expected to reach US$ 360.53 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.
Rise in Prevalence of Aortic Aneurysm Loss Fuels North America Peripheral Embolization Coils Market
An aortic aneurysm is a bulging wall of the body's major artery or aorta. According to the American Heart Association's 2023 data, aortic aneurysms were the cause of 150,000 fatalities reported across the world in 2020, indicating a 26% rise from 2010. Smokers and women had greater rates of aneurysmal rupture. Currently, there are no effective medications to prevent the development of aortic aneurysms; the only treatment options are surgical or endovascular repair. Embolization agents are frequently used as substitutes for open surgeries, which are riskier and followed by longer recovery periods. Peripheral vascular embolization coils, cyanoacrylate or fibrin glue, gel foam, and Onyx are among the embolic devices that are commonly used to treat endoleaks from aortic aneurysms. Coiling is a suitable therapy option for peripheral aneurysms since it is less invasive than open surgical repair. Coils can also be used in elective settings to treat some congenital cardiac diseases, fistulas, aneurysms, and arterial side branch steal syndrome after coronary artery bypass grafting. Therefore, an upsurge in the prevalence of aortic aneurysms drives the growth of the peripheral embolization coils market.
North America Peripheral Embolization Coils Market Overview
The peripheral embolization coils market in North America has been analyzed based on the market scenarios in United States, Canada and Mexico. An upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. Colorectal cancer is the fourth most prevalent cancer in Mexico, with most cases reported after the age of 50, with a comparable distribution of cases in both genders. As a result, the number of new cases and rate of mortality have steadily climbed alongside the rising life expectancy. The peripheral embolization coil market in the United States is experiencing growth due to the increasing prevalence of vascular diseases, such as peripheral artery disease (PAD) and aneurysms, requiring minimally invasive treatment options. Peripheral embolization coils are essential for including blood vessels to prevent hemorrhage or reduce blood flow in targeted areas. As healthcare providers focus on improving patient outcomes with less invasive procedures, the demand for these coils is rising. Technological advancements, such as the development of more efficient and biocompatible coils, along with growing awareness of endovascular treatments, are further driving market expansion in the United States.
Cancer incidences are rising in Mexico, and colorectal cancer is ranked as the third most frequently diagnosed cancer. According to IMSS, every year approximately 15,000 new cases are registered with colon cancer in the country. The market for colorectal cancer in Mexico is expected to grow to increase the campaign for early detection of cancers. According to GLOBOCAN, in Mexico, the incidence rate of gastric cancer was 6.2% in 2020, with a mortality rate of 4.7 per 100,000 persons. Microcoil embolization is a well-established treatment for upper gastrointestinal bleeding that can be performed closer to the bleeding site. The procedure performed using a superselective catheter is a safe and effective way of managing acute lower gastrointestinal bleeding. According to Statista, trauma was the reason for ~600 per 100,000 hospitalizations in Canada in 2021. According to an article published by the Canadian Journal of Surgery (CJS) in 2021, transarterial embolization procedures are successfully being used to treat non-splenic traumatic injuries; the most common embolization technique is coiling with gel foam. These procedures have high success rates with low rates of complications. Moreover, Health Canada has approved numerous coils and coil delivery systems for the treatment of intracranial aneurysms. Coil embolization is used with other adjunct endovascular devices, such as stents and balloons.
North America Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)
North America Peripheral Embolization Coils Market Segmentation
The North America peripheral embolization coils market is categorized into type, material, application, and country.
Based on type, the North America peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.
In terms of material, the North America peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.
By application, the North America peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.
Based on country, the North America peripheral embolization coils market is segmented into the US, Canada, and Mexico. The US dominated the North America peripheral embolization coils market share in 2023.
Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the North America peripheral embolization coils market.